Biochips Market Forecast: What to Expect by 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Forecasted Market Size Estimates For The Biochips Market Between 2025 And 2029?

The overall valuation of the biochips market has experienced swift expansion lately, projected to increase from $12.62 billion in the year 2024 to $14.61 billion in 2025, reflecting a compound annual growth rate of 15.7%; this historical upward trajectory is fundamentally underpinned by several factors, including rising needs for tailored medical treatments, the widespread incidence of long-term health conditions, advancements in technology, broader utilization within the drug identification process, augmented spending on research initiatives, and the presence of favorable regulatory structures.

Significant expansion is projected for the biochips market in the forthcoming years, with its valuation anticipated to reach $25.78 billion by 2029, driven by a compound annual growth rate (CAGR) of 15.2%. This surge throughout the projected timeframe is fueled by several key factors, including the heightened utilization of these devices in diagnostics performed at the site of patient care, broader deployment in the processes of drug development, escalating consumer need for treatments tailored to the individual, technological leaps within microfluidics, increased capital allocation toward research and development, the proliferation of cooperative efforts among academic centers and biotech enterprises, alongside novel avenues surfacing within agricultural biotechnology. Within this forecast window, primary market movements encompass progress in microfluidics engineering, a focal point on creating biochips specifically designed for liquid biopsy procedures, a growing need for assays capable of multiplexing to simultaneously identify numerous target substances, incorporating artificial intelligence methodologies for interpreting gathered data, and the introduction of entirely new biochip system designs.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15737&type=smp

Which Drivers Are Impacting The Biochips Market?

The expanding utilization of treatments designed for the individual is anticipated to boost the biochips market’s expansion moving ahead.When medical care is customized to a person’s unique traits, like their genetic makeup or daily habits, in order to maximize positive outcomes while reducing negative reactions, this is termed personalized medicine.The rising need for these tailored medical approaches stems from their capability to deliver superior therapeutic results, progress in the field of genomics, the escalating intricacy of illnesses, and supportive governmental policies.Biochips facilitate personalized medicine by enabling the creation of exact, patient-specific treatment regimens based on an individual’s genetic blueprint.As an illustration, data from the Personalized Medicine Coalition, a non-profit entity located in the US, indicated that in the year 2023, the FDA authorized sixteen new personalized treatments for individuals suffering from uncommon conditions, contrasting sharply with the six approvals recorded in 2022, specifically in February 2024.Consequently, the rising trend in adopting personalized medical strategies is serving as a catalyst for the biochips market’s upward trajectory.

How Is The Biochips Market Classified Into Different Segments?

The biochipsmarket covered in this report is segmented –

1) By Type: Deoxyribonucleic Acid (DNA) Chips, Protein Chips, Lab-On-Chip, Tissue Arrays, Cell Arrays

2) By Technology: Microarrays, Microfluidics

3) By Application: Drug Discovery And Development, Agriculture, Genomics, Disease Diagnostics, Proteomics, Other Applications

4) By End-User: Biotechnology And Pharmaceutical Companies, Academic And Research Institutes, Hospitals And Diagnostic Centers, Other End-Users

Subsegments:

1) By Deoxyribonucleic Acid (Dna) Chips: Gene Expression Chips, Snp (Single Nucleotide Polymorphism) Chips, Dna Microarrays

2) By Protein Chips: Antibody Arrays, Protein Microarrays, Peptide Arrays

3) By Lab-On-Chip: Microfluidic Devices, Biosensors

4) By Tissue Arrays: Tumor Tissue Arrays, Normal Tissue Arrays

5) By Cell Arrays: Cell-Based Biochips, Cell Signaling Arrays

What Trends Are Expected To Drive The Biochips Market?

Market leaders within the biochips sector are intensely focused on innovating sophisticated solutions, particularly in the realm of organ-on-a-chip systems, with the goal of entirely reshaping how pharmaceuticals are discovered and brought to market. These organ-on-a-chip technologies represent state-of-the-art microfluidic constructs meticulously fabricated to mimic the intricate biological conditions and operational capabilities of human organs, albeit in a miniature configuration. Illustratively, during April of 2024, the American nanotechnology research entity, Boston Micro Fabrication (BMF), established a subsidiary named BMF Biotechnology Inc. This new entity, BMF Biotechnology Inc., is dedicated to producing Biochips, which are synonymous with the organ-on-a-chip apparatuses, engineered to support the in vitro growth of substantial tissue volumes; such breakthroughs significantly speed up the creation timeline for novel therapeutic agents and cosmetic products by offering an alternative testing ground away from direct human application.

Who Are The Core Companies Influencing The Biochips Market Landscape?

Major companies operating in the biochips market are Thermo Fisher Scientific Inc., Roche Diagnostics International Ltd., Zoetis Inc., Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Tecan Group Ltd., Cepheid Inc., Randox Laboratories Ltd., Takara Bio Inc., Oxford Nanopore Technologies plc, Luminex Corporation, Fluidigm Corporation, Micronit Microtechnologies B.V., Sphere Fluidics Limited, Sengenics, Arrayit Corporation, CustomArray Inc., Partek Incorporated, NanoCellect Biomedical Inc., Dolomite Microfluidics, Biocartis NV

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/biochips-global-market-report

What Are The Key Regional Factors Influencing The Biochips Market Growth?

North America was the largest region in the biochips market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biochips market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Biochips Market Report:

https://www.thebusinessresearchcompany.com/customise?id=15737&type=smp

Browse Through More Reports Similar to the Global Biochips Market 2025, By The Business Research Company

Oral Biologics And Biosimilars Market 2025

https://www.thebusinessresearchcompany.com/report/oral-biologics-and-biosimilars-market

Biosimilar Growth Hormone Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/biosimilar-growth-hormone-global-market-report

Microbiomes Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/microbiomes-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795